We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLB icon
3526
State Street Materials Select Sector SPDR ETF
XLB
$8.57B
$52K ﹤0.01%
1,620
-61,670
-97% -$1.92M
CNST
3527
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$52K ﹤0.01%
2,543
-3,553
-58% -$86.7K
HIBS icon
3528
Direxion Daily S&P 500 High Beta Bear 3X ETF
HIBS
$17.6M
$51K ﹤0.01%
+5
New +$59.1K
INMD icon
3529
InMode
INMD
$876M
$51K ﹤0.01%
2,834
+2,180
+333% +$35.8K
MDGL icon
3530
Madrigal Pharmaceuticals
MDGL
$12.4B
$51K ﹤0.01%
434
-1,414
-77% -$154K
NL icon
3531
NLI Holdings
NL
$329M
$51K ﹤0.01%
12,070
+3,089
+34% +$11.1K
OPOF
3532
DELISTED
Old Point Financial
OPOF
$51K ﹤0.01%
3,390
+1,768
+109% +$27.5K
AFIB
3533
DELISTED
Acutus Medical Inc
AFIB
$51K ﹤0.01%
+1,720
New +$52.2K
SCTL
3534
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$51K ﹤0.01%
24,725
+16,128
+188% +$52.9K
SOLY
3535
DELISTED
Soliton, Inc.
SOLY
$51K ﹤0.01%
6,731
+5,464
+431% +$39.3K
CLDB
3536
DELISTED
CORTLAND BNCP CRTLD OHIO
CLDB
$51K ﹤0.01%
3,363
+3,265
+3,332% +$48.3K
ASPS icon
3537
Altisource Portfolio Solutions
ASPS
$64.5M
$50K ﹤0.01%
490
+325
+197% +$31.5K
AUB icon
3538
Atlantic Union Bankshares
AUB
$6.09B
$50K ﹤0.01%
2,297
-6,406
-74% -$146K
BUD icon
3539
AB InBev
BUD
$158B
$50K ﹤0.01%
+936
New +$51.8K
CRDF icon
3540
Cardiff Oncology
CRDF
$77.1M
$50K ﹤0.01%
+3,510
New +$23.2K
EMLC icon
3541
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$50K ﹤0.01%
+1,615
New +$50.5K
FHB icon
3542
First Hawaiian
FHB
$3.36B
$50K ﹤0.01%
3,433
+3,149
+1,109% +$51.8K
MRKR icon
3543
Marker Therapeutics
MRKR
$18.5M
$50K ﹤0.01%
3,327
+2,723
+451% +$49.7K
VIV icon
3544
Telefônica Brasil
VIV
$18.1B
$50K ﹤0.01%
6,499
-11,779
-64% -$107K
ISBC
3545
DELISTED
Investors Bancorp, Inc.
ISBC
$50K ﹤0.01%
6,888
-19,665
-74% -$157K
AKRO
3546
DELISTED
Akero Therapeutics
AKRO
$49K ﹤0.01%
1,578
+36
+2% +$1.26K
CRSP icon
3547
CRISPR Therapeutics
CRSP
$5.22B
$49K ﹤0.01%
588
+345
+142% +$30.6K
DNTH icon
3548
Dianthus Therapeutics
DNTH
$6.13B
$49K ﹤0.01%
449
-53
-11% -$6.28K
FSM icon
3549
Fortuna Silver Mines
FSM
$3.1B
$49K ﹤0.01%
7,737
+5,500
+246% +$35.3K
ITOS
3550
DELISTED
iTeos Therapeutics
ITOS
$49K ﹤0.01%
+1,979
New +$53.2K
140 141
142
143 144

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.